03 Mar 2014
Total Voting Rights

March 3, 2014

At close of business on February 28, 2014, the Company's issued ordinary share capital comprised 587,949,918 ordinary shares of 5 pence each with voting rights and a further 9,823,536 ordinary shares held in treasury.

Therefore the total number of voting rights in the Company is 587,949,918. This is the figure which should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

Tony Guthrie
Deputy Company Secretary

For further information please contact:

Investor Relations
Laurie Stelzer
lstelzer@shire.com
+1 781 482 0733

Eric Rojas
erojas@shire.com
+1 781 482 0999

Sarah Elton-Farr
seltonfarr@shire.com
+44 1256 894157

Notes to editors

Shire enables people with life-altering conditions to lead better lives.

Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.

We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas.

www.shire.com

03 Mar 2014 Total Voting Rights (21KB PDF)

distributed by